Table 1: The characteristics of carbapenem-resistant BSI-PA.
No. | ST | Carbapenemases | Minimum inhibitory concentrations (mg/L) | |||||||||||
CAZ | CFP | FEP | SCF | TZP | IPM | MEM | AMK | CIP | LEV | ATM | MH | |||
P301001 | 1295 | Undetected | 64 | > 256 | 32 | 128 | 256 | 32 | 32 | 8 | > 32 | 64 | 64 | 64 |
P301002 | 316 | VIM | 2 | > 256 | 32 | 128 | 64 | 32 | 16 | 16 | 16 | 32 | 8 | 16 |
P301003 | 270 | Undetected | 32 | > 256 | 32 | 64 | 128 | 32 | 8 | > 512 | 8 | 4 | 8 | 64 |
P301005 | 274 | VIM | 8 | > 256 | 32 | 128 | 128 | 32 | 16 | > 512 | 0.5 | 1 | 8 | 128 |
P301009 | 274 | Undetected | 32 | > 256 | 32 | 128 | 128 | 32 | 16 | > 512 | 0.5 | 1 | 16 | 256 |
P301011 | 316 | IMP | > 64 | 128 | > 64 | 128 | 4 | 32 | 4 | 64 | 0.125 | 0.25 | 2 | 16 |
P301012 | 664 | VIM | 4 | 8 | 4 | 32 | 8 | 16 | 8 | 8 | 1 | 2 | 8 | 64 |
P301013 | 1453 | VIM | 8 | 16 | 8 | 32 | 16 | 32 | 8 | 16 | 1 | 2 | 8 | 16 |
P302004 | 242 | VIM | > 64 | > 256 | 64 | 128 | 256 | 32 | 16 | 2 | 0.25 | 0.125 | 64 | 16 |
P302007 | 560 | VIM | 4 | 8 | 2 | 8 | 8 | 64 | 8 | 4 | 0.25 | 1 | 8 | 16 |
P303004 | 235 | VIM | 32 | 32 | 32 | 64 | 128 | 16 | 16 | 256 | > 32 | 64 | 128 | 32 |
P303009 | 828 | VIM | 8 | 32 | 16 | 64 | 8 | 16 | 16 | 0.5 | 0.5 | 1 | 256 | 128 |
P303015 | 205 | Undetected | 32 | 64 | 32 | 128 | 128 | 64 | 32 | 4 | 0.5 | 2 | > 256 | 32 |
P303016 | OTHER | IMP | 32 | 128 | 16 | 64 | 128 | 32 | 16 | 16 | 0.5 | 1 | 8 | 32 |
P303017 | 235 | IMP | 8 | 128 | 16 | 64 | 64 | 16 | 16 | 128 | > 32 | 32 | 64 | 32 |
P308001 | 498 | VIM | 4 | 8 | 8 | 16 | 8 | 32 | 16 | 8 | 1 | 2 | 32 | 64 |
P308007 | 270 | VIM | 2 | 64 | 16 | 64 | 32 | 16 | 4 | 2 | 16 | 8 | 4 | 16 |
P309008 | OTHER | Undetected | 32 | > 256 | 16 | 8 | 64 | 64 | 64 | 64 | > 32 | 32 | 8 | 32 |
P309009 | 260 | Undetected | 2 | 8 | 2 | 8 | 8 | 16 | 4 | 8 | 0.125 | 0.5 | 8 | 8 |
P309010 | 260 | Undetected | 2 | 8 | 2 | 8 | 4 | 16 | 4 | 8 | 0.125 | 0.5 | 8 | 8 |
P309016 | 971 | VIM | 32 | 256 | 16 | 64 | 128 | 32 | 16 | 8 | 1 | 4 | 128 | 64 |
P311002 | 244 | Undetected | 8 | 64 | 16 | 64 | 32 | 4 | 16 | 16 | > 32 | 64 | 16 | 32 |
P311003 | OTHER | VIM | 8 | > 256 | > 64 | 256 | 128 | 32 | 16 | 8 | 32 | 8 | 16 | 32 |
P311005 | 267 | DIM | 64 | > 256 | > 64 | > 512 | 256 | 32 | 128 | 8 | 1 | 8 | 32 | 32 |
ST: Sequence Type; OTHER: Novel STs that do not exist in the MLST databases of P. aeruginosa; CAZ: Ceftazidime; CFP: Cefoperazone; FEP: Cefepime;
SCF: Cefoperazone/Sulbactam; TZP: Piperacillin/Tazobactam; IPM: Imipenem; MEM: Meropenem; AMK: Amikacin; CIP: Ciprofloxacin; LEV: Levofloxacin; ATM: Aztreonam; MH: Minocycline.